AlphaFold predicted structure
HYAL2 · Q12891

Mean pLDDT
91.0/ 100
Very high
473 residues
Confidence breakdown
- Very high(≥ 90)85%
- Confident(70–90)4%
- Low(50–70)3%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
hyaluronidase 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFamilial non syndromic congenital heart disease
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalPaediatric disorders - additional genes
BIALLELIC, autosomal or pseudoautosomalMuggenthaler-Chowdhury-Chioza syndrome
neurodegenerative disease
cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome
hereditary disease
congenital myopathy 4B, autosomal recessive
amelogenesis imperfecta
Hypomaturation amelogenesis imperfecta
breast cancer
van der Woude syndrome
Hypoplastic amelogenesis imperfecta
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Hyaluronidase-2
Catalyzes hyaluronan degradation into small fragments that are endocytosed and degraded in lysosomes by HYAL1 and exoglycosidases (PubMed:9712871). Essential for the breakdown of extracellular matrix hyaluronan (PubMed:28081210)
HYAL2 · Q12891

Mean pLDDT
91.0/ 100
Very high
473 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0